Online Attendance

TCTAP 2026 provides complimentary live streaming access to selected sessions from the Main Arena and Presentation Theater 1, April 30-May 1, 2026.
  • Online registration will be reopened from April 30 to May 1.
  • All registered participants (On-site and Online) may access the livestream using their registered TCTAP 2026 account.
  • Online-only attendance is not eligible for the certificate of attendance.
Live Streaming Sessions

Thursday, April 30

Main Arena, Level 1

10:10 AM | Live Case
Live Case 1: Left Main

Live Case

Live Case 1: Left Main

Thursday, April 30
10:10 AM ~ 11:10 AM * KST (UTC/GMT +9:00)
Main Arena, Level 1
10:10 AM Asan Medical Center, Korea: Case #1
1st Operator: Jung-Min Ahn
10:40 AM Asan Medical Center, Korea: Case #2
1st Operator: Do-Yoon Kang
11:10 AM | Main Arena
Opening of TCTAP 2026

Main Arena

Opening of TCTAP 2026

Thursday, April 30
11:10 AM ~ 11:25 AM * KST (UTC/GMT +9:00)
Main Arena, Level 1
11:10 AM Welcome Remark
11:15 AM Congratulatory Remark
Speaker: Seok-Min Kang
11:20 AM Brief Overview of TCTAP 2026 Program Highlights
Speaker: Duk-Woo Park
11:25 AM | Main Arena
16th TCTAP Master of the Masters Award

Main Arena

16th TCTAP Master of the Masters Award

Thursday, April 30
11:25 AM ~ 11:55 AM * KST (UTC/GMT +9:00)
Main Arena, Level 1
11:25 AM Award Presentation
11:40 AM Six Decades of Coronary Artery Interventions: Lessons Learned
1:30 PM | Live Case
Live Case & Lecture 2: Complex TAVR

Live Case

Live Case & Lecture 2: Complex TAVR

Thursday, April 30
1:30 PM ~ 2:47 PM * KST (UTC/GMT +9:00)
Main Arena, Level 1
1:30 PM Asan Medical Center, Korea: Case #3
1st Operator: Duk-Woo Park
2nd Operator: Ju Hyeon Kim
2:00 PM Asan Medical Center, Korea: Case #4
Operator(s): Jung-Min Ahn, Ho Jin Kim
2:30 PM [Featured Lecture] Contemporary TAVR: Best Practices and the Road Ahead
Lecturer: Eberhard Grube
2:42 PM Discussion
4:30 PM | Live Case
Live Case 3: CTO

Live Case

Live Case 3: CTO

Thursday, April 30
4:30 PM ~ 5:30 PM * KST (UTC/GMT +9:00)
Main Arena, Level 1
4:30 PM Severance Hospital, Korea: Case #5
1st Operator: Byeong-Keuk Kim
5:00 PM Toyohashi Heart Center, Japan: Case #6
1st Operator: Maoto Habara

Presentation Theater 1, Level 1

8:30 AM | TCTAP Workshops
When to Consider CTO PCI: From Decision to Execution

TCTAP Workshops

When to Consider CTO PCI: From Decision to Execution

Thursday, April 30
8:30 AM ~ 9:50 AM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1

Concept of CTO PCI

8:30 AM CTO PCI - When Is It Truly Indicated?: A Guideline-Based Perspective
Lecturer: Jung-Min Ahn
8:38 AM OMT vs. PCI for Single-Vessel CTO: A Combined Analysis From DECISION-CTO and EUROCTO Trials
Lecturer: Gerald Werner
8:46 AM Panel Discussion I

Strategy for Successful CTO PCI

8:56 AM CT Planning for Successful CTO PCI
Lecturer: Scott Harding
9:04 AM How to Perform CTO Safely and Manage Complication
Lecturer: Shozo Ishihara
9:12 AM How to Master Wire Escalation in CTO PCI: Tips, Tools, and Techniques
Lecturer: Kenya Nasu
9:20 AM Conventional CTO-PCI vs. Hybrid CTO-PCI: Which One Should I Follow?
9:28 AM Navigating the CTO Crossing Algorithm: The 2026 APCTO Perspective
Lecturer: Eugene Brian Wu
9:36 AM Panel Discussion II
4:20 PM | TCTAP Workshops
Mitral and Tricuspid Intervention: Practical Strategies and Techniques

Friday, May 1

Presentation Theater 1, Level 1

8:30 AM | Clinical Science
Late-Breaking Clinical Trials 2026

Clinical Science

Late-Breaking Clinical Trials 2026

Friday, May 1
8:30 AM ~ 9:55 AM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
8:30 AM Early Surgery Versus Conservative Management for Asymptomatic Severe Aortic Stenosis: Final Outcomes of the RECOVERY Trial
Lecturer: Duk Hyun Kang
8:38 AM A Large-Scale, Global Randomized Trial of Coronary Physiology Derived From Conventional Angiography Compared With an Invasive Pressure Wire-Based Approach to Guide Percutaneous Coronary Intervention
8:46 AM Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/​dL; Ez-PAVE Trial
Lecturer: Byeong-Keuk Kim
8:54 AM Panel Discussion I
9:09 AM Ticagrelor Versus Prasugrel in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Data From TUXEDO-2 Trial
9:17 AM Appropriate Duration of Antiplatelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug-Eluting Stents : ADAPT AF-DES Trial
Lecturer: Jung-Sun Kim
9:25 AM Temporal Modulation of Antiplatelet Therapy in High-Risk Patients Undergoing Complex Percutaneous Coronary Intervention: TAILORED-CHIP Trial
Lecturer: Hanbit Park
9:33 AM Optimal Timing of FFR-Guided Complete Revascularization for Non-Infarct-Related Artery in STEMI With Multivessel Disease : OPTION–STEMI Trial
Lecturer: Youngkeun Ahn
9:41 AM Panel Discussion II
If you have any questions about conference or registration, please check FAQ first and contact us.